Skip Main Navigation
Page Content
This event has ended

Xconomy Xchange: Boston Life Sciences 2032

Xconomy

Thursday, October 4, 2012 at 6:00 PM (EDT)

Ticket Information

Ticket Type Sales End Price Fee Quantity
Regular Registration Ended $130.00 $0.00
Startup Special
For employees of startups less than 3 years old with 20 or fewer employees.
Ended $60.00 $0.00
Student
Full-time students only; limited number available. Valid student ID must be shown at registration desk.
Ended $30.00 $0.00
At the Door Ended $175.00 $0.00

Share Xconomy Xchange: Boston Life Sciences 2032

Event Details

Xconomy Xchange: Boston Life Sciences 2032

What will the Boston life sciences landscape look like two decades from today? Will this region remain the world's leader in university, hospital, and corporate research; drug and platform development; and startup activity? Even more, will area companies be shaping a new era in healthcare--and what new advances might make that possible? Four years after we first posed these sorts of questions at our inaugural Xconomy biotech evening, we're assembling another select group of life sciences leaders, innovators, and venture investors to help us lift our heads up from day-to-day challenges and look to the region’s future.

The participants in this intimate conversation:

Deb Dunsire

Deborah Dunsire is President and CEO of Millennium: The Takeda Oncology Company. With 20-plus years of pharmaceutical business experience, she leads an innovative biotechnology company that discovers and develops new medicines that change standards of care in cancer treatment. Dr. Dunsire received the 2011 MassBio Innovative Leadership award.

Noubar Afeyan

Noubar Afeyan is founder, Managing Partner, and CEO of Flagship Ventures. He is also a Senior Lecturer at MIT’s Sloan School of Management. During his 25-year career as inventor, entrepreneur, CEO and venture capitalist, he has co-founded and helped build 25 life science and technology startups.

Dennis A. Ausiello, MD

Dennis A. Ausiello, MD is the Jackson Professor of Clinical Medicine at Harvard Medical School, Chief of Medicine at Massachusetts General Hospital (MGH), and Chief Scientific Officer of Partners Healthcare. Dr. Ausiello serves on the Board of Directors of Pfizer; drug delivery company TARIS; the nonprofit organization, Research!America; and the Broad Institute of Harvard and MIT.

Michael Bonney

Michael W. Bonney is CEO and a director of Cubist Pharmaceuticals. Prior to joining Cubist in 2002, he held senior level positions at Biogen, and spent 11 years at Zeneca Pharmaceuticals. Mr. Bonney is a director of NPS Pharmaceuticals and the Pharmaceutical Research and Manufacturers of America (PhRMA).

John Mendlein

John Mendlein (moderator) is Executive Chairman and CEO of aTyr Pharma (novel protein therapeutics) and Vice Chairman of Fate Therapeutics (drugs for stem cells), two San Diego biotech companies. Prior to aTyr and Fate, he served in leadership and board roles at Aurora (now Vertex) and Adnexus (now a BMS company), both of which were founded on inventions from Nobel Laureates, Roger Tsien and Jack Szostak, respectively.

 


Twitter:

@Xconomy
#ls2032 

Schedule:
Registration & Networking: 5:00 - 6:00 pm
Program: 
6:00 – 7:30 pm
Networking Reception: 7:30
– 8:30 pm

Registration information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.


EVENT HOST

Millennium: The Takeda Oncology Company


EVENT SPONSORS

BDO                                  Cubist Pharmaceuticals


Halloran Consulting Group


Perkins+Will


EVENT PARTNER

MassBio


CHARTER UNDERWRITERS
Alexandria Real Estate Equities

Biogen Idec
WilmerHale

UNDERWRITERS
BDO
Cubist Pharmaceuticals Guard Dog Brand Development
Halloran Consulting Group
• IDA Ireland Kauffman Foundation
Kilpatrick Townsend • Latham & Watkins SRI International Turnstone

VENTURE CAPITAL MEMBERS
Advanced Technology Ventures
ARCH Venture Partners • Avalon Ventures 
Boston Millennia Partners  Fairhaven Capital Flagship VenturesNorth Bridge Venture Partners
Polaris Venture PartnersSR One Third Rock Ventures

Have questions about Xconomy Xchange: Boston Life Sciences 2032? Contact Xconomy

When & Where


Millennium: Takeda
35 Landsdowne St.
Cambridge, 02139

Thursday, October 4, 2012 at 6:00 PM (EDT)


  Add to my calendar

Organizer

Xconomy

Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.

Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.